OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 76 filers reported holding OCULAR THERAPEUTIX INC in Q2 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $116,000 | -71.1% | 11,584 | -59.1% | 0.00% | -75.0% |
| Q2 2021 | $401,000 | +568.3% | 28,300 | +86.8% | 0.00% | +100.0% |
| Q4 2018 | $60,000 | -96.2% | 15,146 | -91.1% | 0.00% | -98.7% |
| Q1 2017 | $1,575,000 | -17.8% | 169,628 | -25.9% | 0.16% | -36.3% |
| Q4 2016 | $1,916,000 | +1239.9% | 228,901 | +995.1% | 0.25% | +933.3% |
| Q3 2016 | $143,000 | +47.4% | 20,903 | +6.3% | 0.02% | +9.1% |
| Q2 2016 | $97,000 | – | 19,670 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $79,675,000 | 100.00% |
| Opaleye Management Inc. | 6,480,000 | $91,886,000 | 15.26% |
| DELTEC ASSET MANAGEMENT LLC | 2,167,313 | $30,732,000 | 4.23% |
| Kamunting Street Capital Management, L.P. | 624,201 | $8,851,000 | 3.58% |
| GREAT POINT PARTNERS LLC | 919,887 | $13,044,000 | 2.74% |
| Endurant Capital Management LP | 570,970 | $8,096,000 | 2.22% |
| Rubric Capital Management LP | 2,156,542 | $30,580,000 | 1.92% |
| Affinity Asset Advisors, LLC | 250,000 | $3,545,000 | 1.27% |
| Altium Capital Management LP | 256,152 | $3,632,000 | 0.84% |
| Ikarian Capital, LLC | 700,000 | $9,928,000 | 0.80% |